A new chemical method that could speed up the creation of medicines, materials and products people rely on every day has been ...

The molecular combinations involved in creating new treatments are vast, so Nvidia is customizing its technology to address ...

Excelsior Sciences said on Wednesday it has raised $95 million to develop technology that uses machines and artificial ...

In a university lab, an AI system generated millions of novel molecules to fight drug-resistant infections. And they're ...

Seattle biotech startup Curi Bio today announced $10 million in new funding. The company enables the screening of new drugs using 3D tissue models.

Artificial intelligence chemistry outfit Excelsior Sciences is gaining ground on its quest to hasten the discovery and production of small molecules. | Excelsior Sciences, which spun out of investment ...

Iambic, a clinical-stage life science and technology company that uses artificial intelligence to develop medicines has ...

Wockhardt’s stock price fell 93% from Rs 2,169 in March 2013 to Rs 145 by March 2023. Yet even in this period, Khorakiwala ...

In this interview, Kalpana Barnes highlights how new approach methodologies are addressing the gaps in drug discovery studies ...

In the face of US federal funding cuts, biomedical researchers propose strategies for continued progress in drug discovery.

Germany's Merck KGaA on Thursday agreed to use Boston-based Valo Health's drug research services in a collaboration focused ...